Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.

Noorduyn SG, Valliant SN, Gould S, Yu LH, Chang R, Song R, Pinaire M, Young-Xu L, Duh MS, Aliberti S

Open source

DOI
10.1007/s12325-026-03692-3
Published
2026 Aug 22
Container
Advances in therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03692-3,
  title = {Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.},
  author = {Noorduyn SG and Valliant SN and Gould S and Yu LH and Chang R and Song R and Pinaire M and Young-Xu L and Duh MS and Aliberti S},
  year = {2026},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-026-03692-3},
  url = {https://doi.org/10.1007/s12325-026-03692-3}
}

RIS

TY  - JOUR
TI  - Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.
AU  - Noorduyn SG
AU  - Valliant SN
AU  - Gould S
AU  - Yu LH
AU  - Chang R
AU  - Song R
AU  - Pinaire M
AU  - Young-Xu L
AU  - Duh MS
AU  - Aliberti S
PY  - 2026
JO  - Advances in therapy
DO  - 10.1007/s12325-026-03692-3
UR  - https://doi.org/10.1007/s12325-026-03692-3
ER  - 

APA

SG, N., SN, V., S, G., LH, Y., R, C., R, S., M, P., L, Y., MS, D., & S, A. (2026). Clinical Remission is Achievable for Adult Patients with Severe Asthma Receiving Mepolizumab: A European Retrospective Chart Review.. Advances in therapy. https://doi.org/10.1007/s12325-026-03692-3

Source records